世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies, Chemistry), By Model Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033
Preclinical CRO Market Summary The global preclinical CRO market size was estimated at USD 6.19 billion in 2024 and is projected to reach USD 12.37 billion by 2033, growing at a CAGR of 8.03% f... もっと見る
英語原文をAIを使って翻訳しています。
SummaryPreclinical CRO Market SummaryThe global preclinical CRO market size was estimated at USD 6.19 billion in 2024 and is projected to reach USD 12.37 billion by 2033, growing at a CAGR of 8.03% from 2025 to 2033. The market is driven escalating R&D investments, the growing complexity of drug development, and the shifting demand toward specialized and advanced therapeutic modalities. The market is primarily driven by the increasing complexity of drug discovery, along with the high costs of in-house research infrastructure, is driving greater adoption of preclinical CRO services. Drug developers are outsourcing studies such as toxicology, pharmacology, and bioanalysis to specialized service providers to reduce time-to-market and manage operational risks. This trend is further amplified by the growing prevalence of chronic and complex diseases, which require more extensive preclinical evaluations. Outsourcing also enables smaller biotech firms, which often have limited resources, to access advanced technologies and global expertise without the need for large-scale internal setups. Global Preclinical CRO Market Report Segmentation This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preclinical CRO market report based on service, model type, end-use, and region: • Service Outlook (Revenue, USD Million, 2021 - 2033) • Bioanalysis and DMPK studies o In vitro ADME o In-vivo PK • Toxicology Testing o GLP o Non-GLP • Compound Management o Process R&D o Custom Synthesis o Others • Chemistry o Medicinal Chemistry o Computation Chemistry • Safety Pharmacology • Others • Model Type Outlook (Revenue, USD Million, 2021 - 2033) • Patient Derived Organoid (PDO) Model • Patient derived xenograft model • End-use Outlook (Revenue, USD Million, 2021 - 2033) • Biopharmaceutical Companies • Government and Academic Institutes • Medical Device Companies • Regional Outlook (Revenue, USD Million, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Norway o Sweden • Asia Pacific o Japan o China o India o Australia o South Korea o Thailand • Latin America o Brazil o Argentina • Middle East and Africa (MEA) o South Africa o Saudi Arabia o UAE o Kuwait o Oman o Qatar Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation and Scope 1.2. Market Definitions 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased database 1.4.2. GVR’s internal database 1.4.3. Secondary sources 1.4.4. Primary research 1.5. Information or Data Analysis 1.5.1. Data analysis models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity flow analysis (Model 1) 1.7.2. Value chain based analysis (Model 2) 1.7.3. Multivariate Analysis (Model 3) 1.8. List of Secondary Sources 1.9. List of Primary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot Chapter 3. Preclinical CRO Market: Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Ancillary Market Outlook 3.2. Preclinical CRO Market Dynamics 3.2.1. Market Driver Impact Analysis 3.2.2. Market Restraint Analysis 3.3. Technological Landscape 3.4. Pricing Model Analysis 3.5. Preclinical CRO Market: Analysis Tools 3.5.1. Porter’s Five Forces Analysis 3.5.2. PESTEL Analysis Chapter 4. Preclinical CRO Market: Service Estimates & Trend Analysis 4.1. Segment Dashboard 4.2. Global Preclinical CRO Market Service Movement Analysis 4.3. Global Preclinical CRO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million) 4.4. Bioanalysis and DMPK Studies 4.4.1. Bioanalysis and DMPK Studies Market Estimates and Forecasts, 2021 - 2033 (USD million) 4.4.2. In vitro ADME 4.4.2.1. In vitro ADME Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.4.3. In-vivo PK 4.4.3.1. In-vivo PK Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5. Toxicology Testing 4.5.1. Toxicology Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5.2. GLP 4.5.2.1. GLP Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5.3. Non-GLP 4.5.3.1. Non-GLP Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.6. Compound Management 4.6.1. Compound Management Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.6.2. Process R&D 4.6.2.1. Process R&D Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.6.3. Custom Synthesis 4.6.3.1. Custom Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.6.4. Others 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.7. Chemistry 4.7.1. Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.7.2. Medicinal Chemistry 4.7.2.1. Medicinal Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.7.3. Computation Chemistry 4.7.3.1. Computation Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.8. Safety Pharmacology 4.8.1. Safety Pharmacology Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.9. Others 4.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 5. Preclinical CRO Market: Model Type Estimates & Trend Analysis 5.1. Segment Dashboard 5.2. Global Preclinical CRO Market Model type Movement Analysis 5.3. Global Preclinical CRO Market Size & Trend Analysis, by Model type, 2021 to 2033 (USD Million) 5.4. Patient Derived Organoid (PDOs) Models 5.4.1. Patient Derived Organoid (PDOs) Models Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.5. Patient Derived Xenograft (PDX) Models 5.5.1. Patient Derived Xenograft (PDX) Models Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 6. Preclinical CRO Market: End Use Estimates & Trend Analysis 6.1. Segment Dashboard 6.2. Global Preclinical CRO Market End Use Movement Analysis 6.3. Global Preclinical CRO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million) 6.4. Biopharmaceutical Companies 6.4.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5. Government and Academic Institutes 6.5.1. Government and Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.6. Medical Device Companies 6.6.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 7. Preclinical CRO Market: Regional Estimates & Trend Analysis by Service, Model Type, End Use 7.1. Regional Market Dashboard 7.2. Global Regional Market Snapshot 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033: 7.4. North America 7.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.4.2. U.S. 7.4.2.1. Key Country Dynamics 7.4.2.2. Competitive Scenario 7.4.2.3. Regulatory Framework 7.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.4.3. Canada 7.4.3.1. Key Country Dynamics 7.4.3.2. Competitive Scenario 7.4.3.3. Regulatory Framework 7.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.4.4. Mexico 7.4.4.1. Key Country Dynamics 7.4.4.2. Competitive Scenario 7.4.4.3. Regulatory Framework 7.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5. Europe 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.2. UK 7.5.2.1. Key Country Dynamics 7.5.2.2. Competitive Scenario 7.5.2.3. Regulatory Framework 7.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.3. Germany 7.5.3.1. Key Country Dynamics 7.5.3.2. Competitive Scenario 7.5.3.3. Regulatory Framework 7.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.4. France 7.5.4.1. Key Country Dynamics 7.5.4.2. Competitive Scenario 7.5.4.3. Regulatory Framework 7.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.5. Italy 7.5.5.1. Key Country Dynamics 7.5.5.2. Competitive Scenario 7.5.5.3. Regulatory Framework 7.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.6. Spain 7.5.6.1. Key Country Dynamics 7.5.6.2. Competitive Scenario 7.5.6.3. Regulatory Framework 7.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.7. Denmark 7.5.7.1. Key Country Dynamics 7.5.7.2. Competitive Scenario 7.5.7.3. Regulatory Framework 7.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.8. Sweden 7.5.8.1. Key Country Dynamics 7.5.8.2. Competitive Scenario 7.5.8.3. Regulatory Framework 7.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.9. Norway 7.5.9.1. Key Country Dynamics 7.5.9.2. Competitive Scenario 7.5.9.3. Regulatory Framework 7.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6. Asia Pacific 7.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.2. Japan 7.6.2.1. Key Country Dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory Framework 7.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.3. China 7.6.3.1. Key Country Dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory Framework 7.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.4. India 7.6.4.1. Key Country Dynamics 7.6.4.2. Competitive Scenario 7.6.4.3. Regulatory Framework 7.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.5. Australia 7.6.5.1. Key Country Dynamics 7.6.5.2. Competitive Scenario 7.6.5.3. Regulatory Framework 7.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.6. South Korea 7.6.6.1. Key Country Dynamics 7.6.6.2. Competitive Scenario 7.6.6.3. Regulatory Framework 7.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.7. Thailand 7.6.7.1. Key Country Dynamics 7.6.7.2. Competitive Scenario 7.6.7.3. Regulatory Framework 7.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.7. Latin America 7.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.7.2. Brazil 7.7.2.1. Key Country Dynamics 7.7.2.2. Competitive Scenario 7.7.2.3. Regulatory Framework 7.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.7.3. Argentina 7.7.3.1. Key Country Dynamics 7.7.3.2. Competitive Scenario 7.7.3.3. Regulatory Framework 7.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8. MEA 7.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.2. South Africa 7.8.2.1. Key Country Dynamics 7.8.2.2. Competitive Scenario 7.8.2.3. Regulatory Framework 7.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.3. Saudi Arabia 7.8.3.1. Key Country Dynamics 7.8.3.2. Competitive Scenario 7.8.3.3. Regulatory Framework 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.4. UAE 7.8.4.1. Key Country Dynamics 7.8.4.2. Competitive Scenario 7.8.4.3. Regulatory Framework 7.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.5. Kuwait 7.8.5.1. Key Country Dynamics 7.8.5.2. Competitive Scenario 7.8.5.3. Regulatory Framework 7.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.6. Oman 7.8.6.1. Key Country Dynamics 7.8.6.2. Competitive Scenario 7.8.6.3. Regulatory Framework 7.8.6.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.7. Qatar 7.8.7.1. Key Country Dynamics 7.8.7.2. Competitive Scenario 7.8.7.3. Regulatory Framework 7.8.7.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 8. Competitive Landscape 8.1. Company Categorization 8.2. Preclinical CRO Market Share Analysis, 2024 8.3. Company Profiles 8.3.1. Eurofins Scientific 8.3.1.1. Company overview 8.3.1.2. Financial performance 8.3.1.3. Product benchmarking 8.3.1.4. Strategic initiatives 8.3.2. PRA Health Sciences, Inc. 8.3.2.1. Company overview 8.3.2.2. Financial performance 8.3.2.3. Product benchmarking 8.3.2.4. Strategic initiatives 8.3.3. Wuxi AppTec 8.3.3.1. Company overview 8.3.3.2. Financial performance 8.3.3.3. Product benchmarking 8.3.3.4. Strategic initiatives 8.3.4. Medpace, Inc. 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Charles River Laboratories International, Inc. 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. PPD Thermo Fisher Scientific, Inc. 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. SGA SA 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Intertek Group Plc (IGP) 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. LABCORP 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Crown Bioscience 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives List of Tables/GraphsList of TablesTable 1 List of abbreviation Table 2 North America Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million) Table 3 North America Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 4 North America Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 5 North America Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 6 U.S. Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 7 U.S. Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 8 U.S. Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 9 Canada Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 10 Canada Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 11 Canada Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 12 Mexico Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 13 Mexico Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 14 Mexico Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 15 Europe Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million) Table 16 Europe Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 17 Europe Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 18 Europe Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 19 UK Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 20 UK Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 21 UK Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 22 Germany Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 23 Germany Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 24 Germany Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 25 France Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 26 France Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 27 France Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 28 Italy Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 29 Italy Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 30 Italy Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 31 Spain Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 32 Spain Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 33 Spain Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 34 Norway Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 35 Norway Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 36 Norway Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 37 Denmark Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 38 Denmark Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 39 Denmark Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 40 Sweden Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 41 Sweden Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 42 Sweden Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 43 Asia Pacific Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million) Table 44 Asia Pacific Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 45 Asia Pacific Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 46 Asia Pacific Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 47 Japan Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 48 Japan Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 49 Japan Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 50 China Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 51 China Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 52 China Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 53 India Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 54 India Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 55 India Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 56 Australia Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 57 Australia Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 58 Australia Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 59 South Korea Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 60 South Korea Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 61 South Korea Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 62 Thailand Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 63 Thailand Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 64 Thailand Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 65 Latin America Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million) Table 66 Latin America Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 67 Latin America Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 68 Latin America Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 69 Brazil Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 70 Brazil Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 71 Brazil Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 72 Argentina Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 73 Argentina Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 74 Argentina Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 75 MEA Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million) Table 76 MEA Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 77 MEA Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 78 MEA Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 79 South Africa Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 80 South Africa Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 81 South Africa Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 82 Saudi Arabia Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 83 Saudi Arabia Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 84 Saudi Arabia Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 85 Kuwait Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 86 Kuwait Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 87 Kuwait Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 88 UAE Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 89 UAE Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 90 UAE Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 91 Oman Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 92 Oman Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 93 Oman Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million) Table 94 Qatar Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million) Table 95 Qatar Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million) Table 96 Qatar Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)List of Figures Fig. 1 Preclinical CRO market segmentation Fig. 2 Market research process Fig. 3 Information procurement Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Market formulation & validation Fig. 7 Commodity flow analysis Fig. 8 Value-Chain-Based Sizing & Forecasting Fig. 9 QFD model sizing & forecasting Fig. 10 Bottom-up approach Fig. 11 Market snapshot Fig. 12 Segment snapshot Fig. 13 Segment snapshot Fig. 14 Segment snapshot Fig. 15 Competitive landscape snapshot Fig. 16 Parent market outlook, 2024 (USD Million) Fig. 17 Ancillary market outlook, 2024 (USD Million) Fig. 18 Preclinical CRO market dynamics Fig. 19 Total R&D drug pipeline size, 2021-2024 Fig. 20 Total drug pipeline by development phase, 2024 Fig. 21 Porter’s five forces analysis Fig. 22 PESTEL analysis Fig. 23 Preclinical CRO market Service outlook: Segment dashboard Fig. 24 Preclinical CRO market, by Service segment: Market share, 2025 & 2033 Fig. 25 Bioanalysis and DMPK Studies market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 26 In vitro ADME market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 27 In-vivo PK market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 28 Toxicology Testing market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 29 GLP market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 30 Non-GLP market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 31 Compound Management market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 32 Process R&D market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 33 Custom Synthesis market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 34 Others market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 35 Chemistry market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 36 Medicinal Chemistry market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 37 Computation Chemistry market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 38 Preclinical CRO market Model type outlook: Segment dashboard Fig. 39 Preclinical CRO market, by Model type segment: Market share, 2025 & 2033 Fig. 40 Patient Derived Organoid (PDOs) Models market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 41 Patient Derived Xenograft (PDX) Models market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 42 Preclinical CRO market End Use outlook: Segment dashboard Fig. 43 Preclinical CRO market, by End Use segment: Market share, 2025 & 2033 Fig. 44 Biopharmaceutical Companies market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 45 Government and Academic Institutes market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 46 Medical Device Companies market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 47 Regional market: Key takeaways Fig. 48 Regional marketplace: Key takeaways Fig. 49 North America Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 50 Key country dynamics Fig. 51 U S Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 52 Key country dynamics Fig. 53 Canada Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 54 Key country dynamics Fig. 55 Mexico Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 56 Europe Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 57 Key country dynamics Fig. 58 UK Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 59 Key country dynamics Fig. 60 Germany Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 61 Key country dynamics Fig. 62 France Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 63 Key country dynamics Fig. 64 Italy Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 65 Key country dynamics Fig. 66 Spain Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 67 Key country dynamics Fig. 68 Denmark Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 69 Key country dynamics Fig. 70 Norway Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 71 Key country dynamics Fig. 72 Sweden Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 73 Asia Pacific Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 74 Key country dynamics Fig. 75 Japan Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 76 Key country dynamics Fig. 77 China Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 78 Key country dynamics Fig. 79 India Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 80 Key country dynamics Fig. 81 Australia Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 82 Key country dynamics Fig. 83 South Korea Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 84 Key country dynamics Fig. 85 Thailand Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 86 Latin America Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 87 Key country dynamics Fig. 88 Brazil Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 89 Key country dynamics Fig. 90 Argentina Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 91 MEA Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 92 Key country dynamics Fig. 93 South Africa Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 94 Key country dynamics Fig. 95 Saudi Arabia Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 96 Key country dynamics Fig. 97 Kuwait Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 98 Key country dynamics Fig. 99 UAE Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 100 Key country dynamics Fig. 101 Oman Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 102 Key country dynamics Fig. 103 Qatar Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 104 Market participant categorization Fig. 105 Heat map analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Grand View Research社の 医療機器分野 での最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
